Cargando…

Frontline Maintenance Treatment for Ovarian Cancer

PURPOSE OF REVIEW: Advanced epithelial ovarian cancer remains the most lethal gynaecological cancer. Most patients with advanced disease will relapse within 3 years after primary treatment with surgery and chemotherapy. Recurrences become increasing difficult to treat due to the emergence of drug re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elyashiv, Osnat, Wong, Yien Ning Sophia, Ledermann, Jonathan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Gynecologic Cancers (J Brown and RW Naumann, Section Editors)
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203502/ https://www.ncbi.nlm.nih.gov/pubmed/34125335 http://dx.doi.org/10.1007/s11912-021-01088-w

Ejemplares similares

Immune checkpoint inhibitors in ovarian cancer: where do we stand?
por: Leary, Alexandra, et al.
Publicado: (2021)

A combined clinical and genetic model for predicting risk of ovarian cancer
por: Dite, Gillian S., et al.
Publicado: (2022)

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors
por: Miller, Rowan E, et al.
Publicado: (2022)

First-Line Management of Advanced High-Grade Serous Ovarian Cancer
por: Mahmood, Reem D., et al.
Publicado: (2020)

Cell therapies in ovarian cancer
por: Sarivalasis, Apostolos, et al.
Publicado: (2021)

Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension
por: Dikalov, Sergey, et al.
Publicado: (2022)

Targeting inflammation in hypertension
por: Deussen, Andreas, et al.
Publicado: (2023)

The Impact of High-Dose-Rate Brachytherapy: Measuring Clinical Outcomes in the Primary Treatment of Cervical Cancer
por: Song, Jiheon, et al.
Publicado: (2020)

Pathways Controlling Formation and Maintenance of the Osteocyte Dendrite Network
por: Wang, Jialiang S., et al.
Publicado: (2022)

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer
por: Doo, David W., et al.
Publicado: (2020)

Update on Treatment Options for Advanced Bile Duct Tumours: Radioembolisation for Advanced Cholangiocarcinoma
por: Najran, Pavan, et al.
Publicado: (2017)

Health Disparities in Ovarian Cancer: Report From the Ovarian Cancer Evidence Review Conference
por: Mei, Shirley, et al.
Publicado: (2023)

Patterns of Care and Outcomes for Small Cell Carcinoma of the Cervix: A National Retrospective Analysis of 542 Cases
por: Wharton, David, et al.
Publicado: (2019)

Robotic Surgery for Colon and Rectal Cancer
por: Park, Eun Jung, et al.
Publicado: (2016)

Executive Functioning Constructs in Anxiety, Obsessive–Compulsive, Post-Traumatic Stress, and Related Disorders
por: Zainal, Nur Hani, et al.
Publicado: (2022)

Efficacy of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Meta-Analysis of Recent Literature
por: Bhattacharya, Shalini, et al.
Publicado: (2022)

Anxiety-Related Disorders in the Context of Racism
por: MacIntyre, M. Myriah, et al.
Publicado: (2023)

Cognitive Behavioral Therapy for Anxiety Disorders in Youth: Efficacy, Moderators, and New Advances in Predicting Outcomes
por: Pegg, Samantha, et al.
Publicado: (2022)

Executive Summary of the Ovarian Cancer Evidence Review Conference
por: Burke, William, et al.
Publicado: (2023)

Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer
por: Ledermann, Jonathan A., et al.
Publicado: (2019)

First-line Rucaparib Plus Bevacizumab Maintenance Completed One-Year in Germline BRCA1-Mutated Advanced Ovarian Cancer
por: Roy, Somnath, et al.
Publicado: (2022)

Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas
por: Cox, Samantha J., et al.
Publicado: (2017)

Immunotherapy for Esophageal Squamous Cell Carcinoma
por: Kojima, Takashi, et al.
Publicado: (2017)

Research on Climate and Dengue in Malaysia: A Systematic Review
por: Hii, Yien Ling, et al.
Publicado: (2016)

Selecting Adjuvant Treatment for Endometrial Carcinoma Using Molecular Risk Factors
por: Wortman, Bastiaan G., et al.
Publicado: (2019)

The application of risk models based on machine learning to predict endometriosis‐associated ovarian cancer in patients with endometriosis
por: Chao, Xiaopei, et al.
Publicado: (2022)

Gastric Electrical Stimulation for Treatment of Refractory Gastroparesis: the Current Approach to Management
por: Shanker, Aaron, et al.
Publicado: (2021)

Diagnosis and Management of Posterior Cortical Atrophy
por: Yong, Keir X. X., et al.
Publicado: (2023)

PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers
por: Lee, Elizabeth K., et al.
Publicado: (2020)

Pregnancy and Cancer: the INCIP Project
por: Maggen, Charlotte, et al.
Publicado: (2020)

Integrated bioinformatic analysis of dysregulated microRNA‐mRNA co‐expression network in ovarian endometriosis
por: Liu, Yong, et al.
Publicado: (2022)

What Is the Best Preoperative Imaging for Endometrial Cancer?
por: Haldorsen, Ingfrid S., et al.
Publicado: (2016)

Fertility-Sparing and Less Radical Surgery for Cervical Cancer
por: Batman, Samantha H., et al.
Publicado: (2022)

Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
por: Liu, Ying L., et al.
Publicado: (2018)

What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer?
por: Haldorsen, Ingfrid S., et al.
Publicado: (2019)

The Utility of Molecular Imaging in Prostate Cancer
por: Leiblich, Aaron, et al.
Publicado: (2016)

Immunotherapy as a treatment strategy in advanced stage and recurrent endometrial cancer: review of current phase III immunotherapy clinical trials
por: Eskander, Ramez N., et al.
Publicado: (2021)

High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage
por: Veeratterapillay, Rajan, et al.
Publicado: (2016)

Efficacy and safety of PARP inhibitors as the maintenance therapy in ovarian cancer: a meta-analysis of nine randomized controlled trials
por: Shao, Fengping, et al.
Publicado: (2020)

Real-world Outcomes Associated With Poly(ADP-ribose) Polymerase Inhibitor Monotherapy Maintenance in Patients With Primary Advanced Ovarian Cancer
por: Chan, John K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lkajjggj3tdtd41ibvn8j4m6ip